RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 6,740.00
+80.00 (1.20%)
At close: Mar 6, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 57.2 billion as of March 9, 2026. Its market cap has increased by 28.40% in one year.
Market Cap
57.20B
Enterprise Value
61.70B
Revenue
134.21B
Ranking
n/a
PE Ratio
11.70
Stock Price
6,740.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 57.20B, a decrease of -60.05%. That is a compound annual growth rate of -23.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 58.41B | -8.92% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris AI Pharma | 83.95B |
| BL Pharmtech | 82.29B |
| Optipharm.CO.,LTD | 74.67B |
| Sinil Pharmaceutical | 69.28B |
| Cosmax Nbt | 68.86B |
| Jin Yang Pharmaceutical | 60.68B |
| Kyung Nam Pharm | 52.44B |
| Korea Arlico Pharm | 50.20B |